What drugs does LIB THERAPEUTICS, INC. make?

LIB THERAPEUTICS, INC. has 1 FDA-approved drugs.

What therapeutic areas does LIB THERAPEUTICS, INC. focus on?

LIB THERAPEUTICS, INC. focuses primarily on Immunology and Cardiovascular and 1 other therapeutic areas.

← Back

Data updated: Mar 10, 2026

LIB THERAPEUTICS, INC.

ImmunologyCardiovascularDermatology

Biotech

LIB THERAPEUTICS, INC. is a biotechnology company focused on Immunology, Cardiovascular, Dermatology.

2025

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

LEROCHOL 2025-12-12

Type 1 - New Molecular Entity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 76%

0 drugs Phase 3: 5 Phase 2: 3

Cardiovascular 18%

1 drugs

Dermatology 6%

0 drugs Phase 2: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

BAUSCH specialty

Dermatology, Immunology, Cardiovascular

COSETTE other

Cardiovascular, Dermatology, Immunology

BAUSCH AND LOMB specialty

Cardiovascular, Dermatology, Immunology

Pfizer big-pharma

Dermatology, Immunology

PAI HOLDINGS PHARM big-pharma

Dermatology, Cardiovascular, Immunology

LIB THERAPEUTICS, INC.

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info